Genpharmasec Stock Screener | Share Price & Fundamental Analysis
GENPHARMA
Trading & Distributors
Share Price BSE
₹1.25
▼
-0.03 (-2.34%)
Track Genpharmasec share price live with TickJournal's free stock screener.
Analyze Genpharmasec share price history trends and compare 52-week high low
levels.
Calculate GENPHARMA stock fair value using fundamental analysis and view live share price charts.
Determine Genpharmasec share intrinsic value and compare it with current GENPHARMA share price.
Record your Genpharmasec trades in TickJournal's free trading journal and track your portfolio performance.
Genpharmasec Market Cap
₹75.82 Cr.
EPS (TTM)
₹0.02
Dividend Yield
-
Debt to Equity
0.07
GENPHARMA 52 Week High
₹2.33
Genpharmasec 52 Week Low
₹1.13
Operating Margin
-1.00%
Profit Margin
-3.03%
GENPHARMA Revenue (TTM)
₹33.00
EBITDA
-
Net Income
₹-1.00
Total Assets
₹80.00
Total Equity
₹65.00
Genpharmasec Share Price History - Stock Screener Chart
Screen GENPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Genpharmasec Company Profile - Fundamental Screener
Screen Genpharmasec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GENPHARMA shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE861N01036
Genpharmasec Balance Sheet Screener
Screen GENPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 80 | 71 | 20 |
| Current Assets | 27 | 41 | 19 |
| Fixed Assets | 8 | 1 | 0 |
| Liabilities | |||
| Total Liabilities | 80 | 71 | 20 |
| Current Liabilities | 5 | 4 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 65 | 65 | 15 |
| Share Capital | 55 | 55 | 28 |
| Reserves & Surplus | 10 | 9 | -12 |
Genpharmasec Income Statement Screener - Profit & Revenue Analysis
Screen Genpharmasec income statement and profit fundamentals.
Analyze GENPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genpharmasec share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33 | 13 | 15 | 9 | 7 | 6 | 11 | 7 | 8 | 6 | 6 |
| Expenses | 33 | 11 | 15 | 8 | 6 | 5 | 10 | 6 | 8 | 6 | 6 |
| EBITDA | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | -1.00% | 8.00% | -7.00% | 9.00% | 2.00% | 4.00% | 0.00% | 0.00% | -1.00% | 0.00% | 3.00% |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | -1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| EPS | -0.02 | 0.02 | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 |
Genpharmasec Cash Flow Screener - Liquidity Fundamentals
Screen GENPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 3 | -3 | -3 |
| Investing Activities | -15 | -28 | 0 |
| Financing Activities | -1 | 48 | 3 |
| Net Cash Flow | -14 | 17 | 0 |
Genpharmasec Shareholding Pattern Screener
See Genpharmasec shareholding pattern with promoter, FII, and DII holdings.
Check Genpharmasec promoter holding and ownership changes for GENPHARMA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% | 29.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 59.94% | 60.03% | 60.19% | 52.78% | 56.17% | 61.26% | 59.55% | 59.62% |
| Other Holding | 10.08% | 9.99% | 9.83% | 17.24% | 13.84% | 8.76% | 10.47% | 10.40% |
| Shareholder Count | 109,080 | 107,602 | 105,804 | 105,693 | 108,137 | 108,220 | 105,838 | 109,206 |
Genpharmasec Share Dividend Screener - Share Yield Analysis
Check Genpharmasec dividend history with payout and yield data.
View Genpharmasec dividend details including ex-dates and amounts for GENPHARMA stock.
Genpharmasec Stock Index Membership
See which indices include Genpharmasec stock.
Check GENPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genpharmasec Market Events Screener - Corporate Actions
Get Genpharmasec corporate actions including splits, bonuses, and buybacks.
Check Genpharmasec stock events that may affect GENPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.04% | ||
| Change Of Name | NA | 0.00% | ||
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -11.30% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 9.27% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -11.46% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -6.05% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 10.55% |
| 2024-01-09 | 2024-01-09 | Rights | 1:1 | 82.23% |
Genpharmasec Competitors Screener - Peer Comparison
Screen GENPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,526 | 11.29 | 99,562 | 11.11% | 1,821 | 48.15 |
| Elitecon International | 16,485 | 70.49 | 551 | 55040.00% | 70 | 42.47 |
| MMTC | 8,583 | 38.43 | 263 | 28.63% | 87 | 45.71 |
| BN Agrochem | 3,911 | 54.91 | 367 | 5071.83% | 20 | 60.12 |
| MSTC | 3,453 | 8.07 | 388 | -25.38% | 407 | 52.62 |
| Ravindra Energy | 2,951 | 43.40 | 262 | 79.10% | 23 | 56.53 |
| TCC Concept | 2,090 | 43.19 | 90 | 14.72% | 42 | 40.94 |
| Vintage Coffee & Beverages | 2,077 | 37.43 | 313 | 136.92% | 40 | 48.45 |
| Creative Newtech | 1,110 | 18.52 | 1,802 | 3.48% | 53 | 56.44 |
| Polo Queen Industrial And Fintech | 1,108 | 407.75 | 81 | 15.16% | 3 | 45.42 |
Genpharmasec Company Announcements - News Screener
Screen GENPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-11 | Submission Of Clear Copy Of Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September 2025. | View |
| 2025-11-06 | Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter & Half Year Ended 30Th September 2025. | View |
| 2025-11-06 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday November 06 2025. | View |
| 2025-10-27 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 06Th November 2025. | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Notice Of 33Rd Annual General Meeting Of The Company To Be Held On September 29 2025. | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-09-02 | Intimation Of Book Closure For Annual General Meeting | View |
| 2025-09-02 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday 02Nd September 2025. | View |
| 2025-08-28 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday 02Nd September 2025. | View |
| 2025-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-07 | Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June 2025. | View |
| 2025-08-07 | Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2025. | View |